SCHEMBL13638532

SCHEMBL13638532

C=C1CC(Nc2nccc(-c3ccc(CCC(C)(C)N)cc3)n2)CC(C)(C)N1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 14/20 0.39
MAPK8 P45983 4/20 0.36
CHUK O15111 2/20 0.36
CDK1 P06493 3/20 0.34
CDK4 P11802 3/20 0.34
CCNB1 P14635 3/20 0.34
CCNA2 P20248 3/20 0.34
CCND1 P24385 3/20 0.34
CDK2 P24941 3/20 0.34
CCNA1 P78396 3/20 0.34
AURKA O14965 1/20 0.33
TTK P33981 1/20 0.33
AURKB Q96GD4 1/20 0.33
INCENP Q9NQS7 1/20 0.33
MAPK9 P45984 3/20 0.33
MAPK10 P53779 3/20 0.33
MAPK11 Q15759 1/20 0.33
MAPK14 Q16539 1/20 0.33
CCNE1 P24864 1/20 0.32
CCND3 P30281 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13638437 0.91 IKBKB (0.39) IKBKBMAPK8CHUKCDK1CDK4
SCHEMBL13638679 0.89 IKBKB (0.41) IKBKBMAPK8CHUKCDK1CDK4
SCHEMBL13638312 0.88 IKBKB (0.39) IKBKBMAPK8CHUKCDK1CDK4
SCHEMBL13638313 0.87 IKBKB (0.39) IKBKBMAPK8CHUKAURKATTK
SCHEMBL4474400 0.87 IKBKB (0.43) IKBKBMAPK8CHUKAURKATTK
SCHEMBL13638438 0.86 IKBKB (0.39) IKBKBMAPK8CHUKCDK1CDK4
SCHEMBL13638591 0.85 IKBKB (0.37) IKBKBMAPK8CHUKCDK1CDK4
SCHEMBL13638590 0.85 ROCK2 (0.38) IKBKBMAPK8CHUKAURKATTK
SCHEMBL13638538 0.84 IKBKB (0.38) IKBKBMAPK8CHUKCDK1CDK4
SCHEMBL13638531 0.84 SYK (0.43) IKBKBMAPK8CHUK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615562-B2 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents NOVARTIS AG (CH) 2009-11-10 US disclosed